Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ayal Aaron Aizer, M.D.

Co-Author

This page shows the publications co-authored by Ayal Aizer and Patrick Wen.
Connection Strength

2.975
  1. Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol. 2021 09 01; 23(9):1447-1456.
    View in: PubMed
    Score: 0.248
  2. Population-based estimates of survival among elderly patients with brain metastases. Neuro Oncol. 2021 04 12; 23(4):661-676.
    View in: PubMed
    Score: 0.242
  3. Seizures Among Patients with Brain Metastases: A Population- and Institutional-level Analysis. Neurology. 2021 Jan 05.
    View in: PubMed
    Score: 0.237
  4. Utility of claims data for delineation of intracranial treatment among patients with brain metastases. Neuro Oncol. 2020 10 14; 22(10):1547-1548.
    View in: PubMed
    Score: 0.233
  5. Clinical Importance of CDKN2A Loss and Monosomy 10 in Pilocytic Astrocytoma. Cureus. 2019 May 23; 11(5):e4726.
    View in: PubMed
    Score: 0.212
  6. Local control after brain-directed radiation in patients with cystic versus solid brain metastases. J Neurooncol. 2019 Apr; 142(2):355-363.
    View in: PubMed
    Score: 0.208
  7. Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation. Radiother Oncol. 2018 03; 126(3):511-518.
    View in: PubMed
    Score: 0.194
  8. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol. 2017 Oct 19; 19(11):1511-1521.
    View in: PubMed
    Score: 0.190
  9. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study. JAMA Oncol. 2017 Aug 01; 3(8):1069-1077.
    View in: PubMed
    Score: 0.187
  10. A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma. Neuro Oncol. 2016 Feb; 18(2):269-74.
    View in: PubMed
    Score: 0.164
  11. Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer. 2015 Dec 15; 121(24):4376-81.
    View in: PubMed
    Score: 0.163
  12. Radiotherapy and death from cerebrovascular disease in patients with primary brain tumors. J Neurooncol. 2015 Sep; 124(2):291-7.
    View in: PubMed
    Score: 0.161
  13. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol. 2014 Nov; 16(11):1547-53.
    View in: PubMed
    Score: 0.150
  14. A Molecularly Integrated Grade for Meningioma. Neuro Oncol. 2021 Sep 11.
    View in: PubMed
    Score: 0.062
  15. Highlights of the 2019 Society for Neuro-Oncology Inaugural Brain Metastases Conference: establishing a dedicated meeting to address an unmet need in the field. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa036.
    View in: PubMed
    Score: 0.056
  16. A low percentage of metastases in deep brain and temporal lobe structures. Neuro Oncol. 2019 05 06; 21(5):640-647.
    View in: PubMed
    Score: 0.053
  17. Radiographic prediction of meningioma grade by semantic and radiomic features. PLoS One. 2017; 12(11):e0187908.
    View in: PubMed
    Score: 0.048
  18. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone. J Neurooncol. 2017 Dec; 135(3):581-591.
    View in: PubMed
    Score: 0.047
  19. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 2016 05; 18(5):649-55.
    View in: PubMed
    Score: 0.042
  20. Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):384-9.
    View in: PubMed
    Score: 0.040
  21. Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma. Neuro Oncol. 2015 Oct; 17(10):1344-55.
    View in: PubMed
    Score: 0.040
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.